Literature DB >> 5360809

[Treatment of diabetic retinopathy by light-coagulation].

A Wessing, G Meyer-Schwickerath.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5360809     DOI: 10.1007/bf00452905

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

1.  TREATMENT OF DIABETIC RETINOPATHY BY LIGHT-COAGULATION: A PRELIMINARY STUDY.

Authors:  P C WETZIG; J T WORLTON
Journal:  Br J Ophthalmol       Date:  1963-09       Impact factor: 4.638

2.  [The role of photocoagulation in ophthalmology].

Authors:  N M BRAZIL; J REZENDE
Journal:  Bull Mem Soc Fr Ophtalmol       Date:  1961

3.  PROGNOSIS FOR VISION IN DIABETIC RETINOPATHY.

Authors:  F I CAIRD; C J GARRETT
Journal:  Diabetes       Date:  1963 Sep-Oct       Impact factor: 9.461

4.  [A SPECIAL FORM OF THE COURSE OF DIABETIC RETINOPATHY].

Authors:  F FISCHER
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1964-12-09

5.  The intravenous use of fluorescein as an adjunct in light coagulation.

Authors:  P C Wetzig; C N Jepson
Journal:  Bibl Ophthalmol       Date:  1968

6.  The effectiveness of photocoagulation in the therapy of proliferative diabetic retinopathy (PDR). (A controlled study in 50 patients).

Authors:  E Okun
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1968 Mar-Apr

7.  [Further experiences in the use of light coagulation in the treatment of diabetic retinopathy].

Authors:  K Schott
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1965

8.  [New considerations concerning the evolution and treatment of diabetic retinopathy].

Authors:  P Amalric
Journal:  Ophthalmologica       Date:  1967       Impact factor: 3.250

9.  Treatment of diabetic retinopathy by light coagulation.

Authors:  P C Wetzig; C N Jepson
Journal:  Am J Ophthalmol       Date:  1966-09       Impact factor: 5.258

10.  [Diabetic retinopathy. I. Fluorescein angiography in diabetic retinopathy].

Authors:  P Amalric; G Coscas
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1967-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.